- Previous Close
130.32 - Open
133.00 - Bid --
- Ask --
- Day's Range
131.01 - 136.83 - 52 Week Range
49.00 - 136.83 - Volume
4,847,308 - Avg. Volume
1,361,796 - Market Cap (intraday)
27.355B - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
-- - EPS (TTM)
-2.55 - Earnings Date May 21, 2025 - May 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 8, 2023
- 1y Target Est
--
NACL Industries Limited manufactures and sells agrochemicals in India. The company offers a range of technical products, including myclobutanil, propiconazole, profenofos, tricyclazole, pretilachlors, thiamethoxam, lambda cyhalothrin, bifenthrin, azoxystrobin, tebuconazole, thifluzamide, difenoconazole, bispyribac sodium, clodinafop propargyl, metribuzin, quizalofop ethyl, haloxyfop r methyl, and glufosinate ammonium; and formulations, such as insecticides, fungicides, herbicides, and plant growth regulators and nematicides, as well as pesticides and acaricides. It also provides toll manufacturing services for various multinational companies. The company also exports its products. It markets and sells its products through a network of retail dealers. NACL Industries Limited was formerly known as Nagarjuna Agrichem Limited and changed its name to NACL Industries Limited in September 2017. The company was incorporated in 1986 and is based in Hyderabad, India. NACL Industries Limited is a subsidiary of KLR Products Limited.
www.naclind.com1,399
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: NACLIND.NS
View MorePerformance Overview: NACLIND.NS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NACLIND.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NACLIND.NS
View MoreValuation Measures
Market Cap
26.43B
Enterprise Value
31.09B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.78
Price/Book (mrq)
5.18
Enterprise Value/Revenue
2.12
Enterprise Value/EBITDA
171.31
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.43%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
14.9B
Net Income Avi to Common (ttm)
-511.4M
Diluted EPS (ttm)
-2.55
Balance Sheet and Cash Flow
Total Cash (mrq)
553.6M
Total Debt/Equity (mrq)
103.11%
Levered Free Cash Flow (ttm)
--